| A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) (NCT07564154) | Kali Therapeutics, Inc. | 2026-07-13 |
| Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected (NCT06613789) | HIV Vaccine Trials Network | 2026-07-13 |
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants (NCT07629999) | Bristol-Myers Squibb | 2026-07-13 |
| Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors (NCT07583654) | West China Hospital | 2026-07-13 |
| A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa (NCT07709494) | Revagenix, Inc. | 2026-07-13 |
| Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) (NCT07706855) | Beijing Gene Key Life Technology Co., Ltd | 2026-07-10 |
| Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions (NCT07675226) | Oscotec Inc. | 2026-07-10 |
| A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer (NCT07538804) | Avistone Biotechnology Co., Ltd. | 2026-07-10 |
| Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants (NCT07397455) | Imperial College London | 2026-07-10 |
| A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants (NCT07678463) | QuantX Biosciences, Inc. | 2026-07-10 |
| Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects (NCT07584304) | Yuhan Corporation | 2026-07-10 |
| Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria (NCT07224776) | Brigham and Women's Hospital | 2026-07-10 |
| HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma (NCT07697339) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-07-10 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors (NCT07695142) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-09 |
| A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma (NCT07681596) | AstraZeneca | 2026-07-09 |
| A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women (NCT07645235) | GlaxoSmithKline | 2026-07-09 |
| A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function. (NCT07600788) | Ausper Biopharma Co., Ltd. | 2026-07-09 |
| Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections (NCT07704333) | National Institutes of Health Clinical Center (CC) | 2026-07-09 |
| A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD (NCT07567872) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-09 |
| A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma (NCT07710690) | Neuregen Therapeutics Co., Ltd. | 2026-07-09 |
| CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis (NCT07388277) | Marcela V. Maus, M.D.,Ph.D. | 2026-07-09 |
| Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML (NCT07355335) | Massachusetts General Hospital | 2026-07-09 |
| A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) (NCT07717840) | AstraZeneca | 2026-07-08 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants (NCT07658638) | Tes Pharma S.r.l. | 2026-07-08 |
| Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors (NCT07599176) | National Heart, Lung, and Blood Institute (NHLBI) | 2026-07-08 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer (NCT07623356) | Akeso | 2026-07-07 |
| A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body (NCT07525960) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-07-07 |
| Asciminib in HER2+ Breast Cancer Brain Metastases (NCT07136428) | Duke University | 2026-07-07 |
| First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205) | Washington University School of Medicine | 2026-07-07 |
| Stem Cells for Erectile Dysfunction Post RALP (NCT07048314) | The Methodist Hospital Research Institute | 2026-07-07 |
| Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. (NCT05937906) | Centre Georges Francois Leclerc | 2026-07-07 |
| Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments (NCT07618377) | Ono Pharmaceutical Co., Ltd. | 2026-07-07 |
| Cabotegravir-Hormone PK/PD Interactions for HIV Prevention (NCT07672717) | Johns Hopkins University | 2026-07-07 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors (NCT07498725) | LARKSPUR BIOSCIENCES, INC. | 2026-07-07 |
| Single Ascending Dose Study of ATH-097 in Healthy Participants (NCT07640269) | Atheron Therapeutics, Ltd. | 2026-07-06 |
| Study of AHB-171 in Chronic Hepatitis B Participants (NCT07617194) | AusperBio Therapeutics Inc. | 2026-07-06 |
| Mass Balance Study of [14C] Flonoltinib Maleate (NCT07612306) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-07-06 |
| Universal STAR-T Cell Injection in Generalized Myasthenia Gravis (NCT07714798) | Daishi Tian | 2026-07-06 |
| A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants (NCT07717918) | Bausch & Lomb Incorporated | 2026-07-06 |
| A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight (NCT07628127) | Verdiva Bio Dev Limited | 2026-07-06 |
| Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China (NCT07620951) | Alpha Biopharma (Jiangsu) Co., Ltd. | 2026-07-06 |
| A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) (NCT07630974) | Merck Sharp & Dohme LLC | 2026-07-06 |
| A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity (NCT07693868) | Novo Nordisk A/S | 2026-07-06 |
| Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) (NCT07387926) | Novartis Pharmaceuticals | 2026-07-05 |
| Intradiscal rhGDF-6 for the Treatment of Lumbar Disc Degeneration (NCT07668466) | Cartago Biotech Pty Ltd | 2026-07-04 |
| Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression (NCT07655622) | Second Affiliated Hospital of Nanchang University | 2026-07-03 |
| Evaluation of ICP-B208 in Patients With Advanced Solid Tumors (NCT07617493) | Beijing InnoCare Pharma Tech Co., Ltd. | 2026-07-03 |
| A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors (NCT07600476) | Kupando GmbH | 2026-07-03 |
| A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors (NCT07660432) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2026-07-03 |
| A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers (NCT07738991) | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 2026-07-03 |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer (NCT07601620) | Shanghai Henlius Biotech | 2026-07-03 |
| A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) (NCT07698899) | Memorial Sloan Kettering Cancer Center | 2026-07-02 |
| HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. (NCT07748533) | Juventas Cell Therapy Ltd. | 2026-07-02 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants (NCT07626515) | Hoffmann-La Roche | 2026-07-02 |
| A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes (NCT07684586) | GlaxoSmithKline | 2026-07-02 |
| HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension (NCT07644364) | Novartis Pharmaceuticals | 2026-07-02 |
| Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection (NCT07429162) | Alberta Health services | 2026-07-02 |
| Phase 1b/2 Study of IV Sarilumab in Adult With RA (NCT07704580) | Sanofi | 2026-07-02 |
| Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232) | M.D. Anderson Cancer Center | 2026-07-02 |
| COQ10 and Vitamin E for Off-Target Radiation Toxicity (NCT07668284) | University of Nebraska | 2026-07-01 |
| Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma (NCT07479979) | Natalie Callander | 2026-07-01 |
| Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling (NCT07033884) | VA Office of Research and Development | 2026-07-01 |
| Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) (NCT07447557) | Elpida Therapeutics SPC | 2026-07-01 |
| US Zamto-cel Autoimmune Diseases (NCT06708845) | Miltenyi Biomedicine GmbH | 2026-07-01 |
| IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer (NCT07674615) | Shanghai Gynecologic Oncology Group | 2026-07-01 |
| Abdominal aBscess Catheter Sclerotherapy (ABCS) (NCT06906029) | University of Alabama at Birmingham | 2026-07-01 |
| Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer (NCT07665684) | University Health Network, Toronto | 2026-07-01 |
| Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions (NCT07643233) | AJU Pharm Co., Ltd. | 2026-07-01 |
| Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster (NCT07640308) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2026-07-01 |
| Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer (NCT07494448) | MedSIR | 2026-07-01 |
| A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors (NCT07623707) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-01 |
| A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS (NCT07589764) | Duke University | 2026-07-01 |
| Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet (NCT07696091) | Reistone Biopharma Company Limited | 2026-07-01 |
| Study of ECC4703 With Sulfasalazine and Pitavastatin (NCT07726368) | Eccogene | 2026-07-01 |
| Combination Immunotherapy Targeting Sarcomas (NCT04433221) | Shenzhen Geno-Immune Medical Institute | 2026-07-01 |
| EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer (NCT07649655) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2026-07-01 |
| Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies (NCT07662681) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-07-01 |
| Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) (NCT07011589) | M. Peter Marinkovich | 2026-07-01 |
| A Study of Metformin to Improve Cardiac Function After LVAD Implantation (NCT07666698) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-07-01 |
| A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants (NCT07662798) | Eli Lilly and Company | 2026-07-01 |
| Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma (NCT06492954) | Emory University | 2026-07-01 |
| B7-H3.CD28Z.CART in CNS Neoplasms (NCT07390539) | Robbie Majzner | 2026-07-01 |
| Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia (NCT07614282) | Jennifer Amengual | 2026-07-01 |
| Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants (NCT07666750) | International Vaccine Institute | 2026-07-01 |
| A Study in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT07719361) | Flare Therapeutics Inc. | 2026-07-01 |
| Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial (NCT07747324) | University of Sao Paulo | 2026-07-01 |
| A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants (NCT07681479) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| Evaluation of [11C]ZTP-1 to Image PDE4B (NCT07625345) | National Institute of Mental Health (NIMH) | 2026-07-01 |
| Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC (NCT07697040) | Hebei Medical University Fourth Hospital | 2026-07-01 |
| A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL (NCT06979076) | MingSight Pharmaceuticals, Inc | 2026-07-01 |
| Study of GS-0415 and How It Works in People With HIV (NCT07719491) | Gilead Sciences | 2026-07-01 |
| Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT (NCT07675174) | Northwell Health | 2026-07-01 |
| Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MS (NCT07631143) | University of Saskatchewan | 2026-07-01 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers (NCT07715305) | Addpharma Inc. | 2026-07-01 |
| A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (NCT07676266) | The Affiliated Hospital of Qingdao University | 2026-07-01 |
| Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia (NCT07484204) | Anxo Pharmaceutical Co., Ltd. | 2026-07-01 |
| New Genotype-guided Treatment in Newly Diagnosed PTCL (NCT07706959) | Ruijin Hospital | 2026-07-01 |
| A Clinical Study of HRS-8797 in Healthy Participants (NCT07698756) | Chengdu Suncadia Medicine Co., Ltd. | 2026-07-01 |
| Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases (NCT07490275) | Institute of Hematology & Blood Diseases Hospital, China | 2026-07-01 |
| Phase I Trial of pH Resections of GBM at VA (NCT07218367) | VA Office of Research and Development | 2026-07-01 |